It’s only fair to share… The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older. The FDA initially approved Zerbaxa in 2014 to treat complicated intra-abdominal infections …
Onasemnogene abeparvovec オナセムノジーンアベパルボベック
It’s only fair to share… Onasemnogene abeparvovec オナセムノジーンアベパルボベック DNA (synthetic adeno-associated virus 9 vector scAAV9.CB.hSMN human survivor motor neuron protein-specifying) Zolgensma FDA 2019/5/24 APPROVED CAS: 1922968-73-7 AVXS-101 Spinal muscular atrophy treatment Treatment of Spinal Muscular Atrophy (SMA) Type 1 Gene therapy product Onasemnogene abeparvovec, sold under the trade name Zolgensma, is a gene therapy medication used to treat spinal muscular atrophy (SMA). …
FDA approves first PI3K inhibitor Piqray (alpelisib) for breast cancer
It’s only fair to share… FDA approves first PI3K inhibitor for breast cancer syn https://newdrugapprovals.org/2018/06/25/alpelisib-byl-719/ Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced …
CT-1812
It’s only fair to share… CT-1812 Elayta Condition(s): Alzheimer’s Disease U.S. FDA Status: Alzheimer’s Disease (Phase 2) Company: Cognition Therapeutics Inc. CAS: 1802632-22-9 Chemical Formula: C24H33NO4S Molecular Weight: 431.591 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol Phenol, 4-[3-[1,3-dihydro-5-(methylsulfonyl)-2H-isoindol-2-yl]-3-methylbutyl]-2-(1,1-dimethylethoxy)- Originator Cognition Therapeutics Class Antidementias; Neuroprotectants; Nootropics; Small molecules Mechanism of Action Sigma-2 receptor antagonists Phase II Alzheimer’s disease Phase I Cognition disorders 21 Feb 2019 Cognition Therapeutics receives patent for …
Dipivefrine, дипивефрин , ديبيفيفرين , 地匹福林 , ジピベフリン
It’s only fair to share… Dipivefrine Molecular FormulaC19H29NO5 Average mass351.437 Da 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate) 52365-63-6 [RN] (±)-3,4-Dihydroxy-a-[(methylamino)methyl]benzyl Alcohol 3,4-Dipivalate 1-(3′,4′-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol 2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester дипивефрин [Russian] [INN] ديبيفيفرين [Arabic] [INN] 地匹福林 [Chinese] [INN] ジピベフリン 4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate D Epifrin [Trade name] Diopine [Trade name] MFCD00673243 [MDL number] Pivalephrine [Trade name] Pro-Epinephrine Propine [Trade name] Thilodrin [Trade name] ATC:S01EA02 Use:antiglaucoma Dipivefrine hydrochloride CAS 64019-93-8 Formula:C19H29NO5 • HCl MW:387.90 g/mol Dipivefrine (INN) or dipivefrin (USAN), trade name Propine among …
Etosalamide, этосаламид , إيتوسالاميد , 依托柳胺 ,
It’s only fair to share… Etosalamide ethosalamide Cas 15302-15-5 Chemical Formula: C11H15NO3 Molecular Weight: 209.245 o-(2-Ethoxyethoxy)benzamide 1585 1PU994YJUH этосаламид [Russian] [INN] إيتوسالاميد [Arabic] [INN] 依托柳胺 [Chinese] [INN] 2-(2-ethoxyethoxy)benzamide UNII-1PU994YJUH 1PU994YJUH HY-B1015 ZINC3623372 AKOS030526102 CCG-213900 CS-4528 AB01563362_01 SR-01000944263 SR-01000944263-1 Etosalamide, also known as Ethosalamide, is an antipyretic and analgesics agent SYN OR CAS:592-55-2, 2-Bromoethyl ethyl ether Cas, 611-20-1, 2-Hydroxybenzonitrile PATENT DE 1013643 PATENT GB 774635 PATENT US2822391 78 …
GUEST POST, POOJA KUMAR, CURRENT SCENARIO OF PATENTS IN INDIA
It’s only fair to share… CURRENT SCENARIO OF PATENTS IN INDIA By Ms. Pooja Kumar (Registered Patent agent/Director of Innove Intellects) Email id: pooja@innoveintellects.com Patent is a monopoly, exclusive rights given to an individual or a company or an organization to make, sell, use and import an invention for a limited period of years. In …
FDA approves first treatment Ruzurgi (amifampridine) for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder
It’s only fair to share… FDA approves first treatment Ruzurgi (amifampridine) for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder The U.S. Food and Drug Administration today approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age. This is the first FDA …
Beperminogene perplasmid, ベペルミノゲンペルプラスミド
It’s only fair to share… 1gctgcttcgc gatgtacggg ccagatatac gcgttgacat tgattattga 51ctagttatta atagtaatca attacggggt cattagttca tagcccatat 101atggagttcc gcgttacata acttacggta aatggcccgc ctggctgacc 151gcccaacgac ccccgcccat tgacgtcaat aatgacgtat gttcccatag 201taacgccaat agggactttc cattgacgtc aatgggtgga gtatttacgg 251taaactgccc acttggcagt acatcaagtg tatcatatgc caagtacgcc 301ccctattgac gtcaatgacg gtaaatggcc cgcctggcat tatgcccagt 351acatgacctt atgggacttt cctacttggc agtacatcta cgtattagtc 401atcgctatta ccatggtgat gcggttttgg cagtacatca atgggcgtgg 451atagcggttt gactcacggg gatttccaag tctccacccc attgacgtca …
BI-882370
It’s only fair to share… BI-882370 XP-102 N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide CAS 1392429-79-6 Chemical Formula: C28H33F2N7O2S Molecular Weight: 569.68 Elemental Analysis: C, 59.03; H, 5.84; F, 6.67; N, 17.21; O, 5.62; S, 5.63 N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide N-(3-{5-[(1-Ethylpiperidin-4-Yl)(Methyl)amino]-3-(Pyrimidin-5-Yl)-1h-Pyrrolo[3,2-B]pyridin-1-Yl}-2,4-Difluorophenyl)propane-1-Sulfonamide N-[3-[5-[(1-ethylpiperidin-4-yl)-methylamino]-3-pyrimidin-5-ylpyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]propane-1-sulfonamide BI 882370 is a highly potent and selective RAF inhibitor that binds to the DFG-out (inactive) conformation of the BRAF kinase. BI …